{"id":"NCT01905956","sponsor":"InQpharm Group","briefTitle":"Safety and Efficacy of IQP- AK-102 in Reducing Body Weight","officialTitle":"Double-blind, Randomized, Placebo-controlled, Bicentric Clinical Investigation to Evaluate Safety and Efficacy of IQP- AK-102 in Reducing Body Weight in Overweight and Obese Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-07","primaryCompletion":"2014-07","completion":"2014-07","firstPosted":"2013-07-23","resultsPosted":"2016-03-08","lastUpdate":"2016-03-08"},"enrollment":119,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Weight Loss"],"interventions":[{"type":"DIETARY_SUPPLEMENT","name":"IQP-AK-102","otherNames":[]},{"type":"DIETARY_SUPPLEMENT","name":"Placebo","otherNames":[]}],"arms":[{"label":"IQP-AK-102","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The individual ingredients in IQP-AK-102 have been widely used. Backed by data from several studies demonstrating their efficacy, we are conducting this study to look into the efficacy and safety of this novel combination of three fibres, in appetite regulation.","primaryOutcome":{"measure":"Mean Change in Body Weight From Baseline to Week 12","timeFrame":"Baseline and 12 weeks","effectByArm":[{"arm":"IQP-AK-102","deltaMin":3.53,"sd":2.28},{"arm":"Placebo","deltaMin":0.14,"sd":1.84}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":9,"exclusionCount":7},"locations":{"siteCount":1,"countries":["Germany"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":58},"commonTop":["Common cold or upper respiratory tract infection","Headaches and Migraine","Toothache or dental extraction","Distortion and contusion of knee","Nausea & Vomiting"]}}